Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 96


Prediction of upper extremity motor recovery after subacute intracerebral hemorrhage through diffusion tensor imaging: a systematic review and meta-analysis.

Kumar P, Yadav AK, Misra S, Kumar A, Chakravarty K, Prasad K.

Neuroradiology. 2016 Oct;58(10):1043-1050.


Association between Apolipoprotein ε4 Gene Polymorphism and Risk of Ischemic Stroke: A Meta-Analysis.

Kumar A, Kumar P, Prasad M, Misra S, Kishor Pandit A, Chakravarty K.

Ann Neurosci. 2016 Jul;23(2):113-21. doi: 10.1159/000443568. Review.


Bone marrow mononuclear cell therapy in ischaemic stroke: a systematic review.

Kumar A, Prasad M, Jali VP, Pandit AK, Misra S, Kumar P, Chakravarty K, Kathuria P, Gulati A.

Acta Neurol Scand. 2016 Aug 24. doi: 10.1111/ane.12666. Review.


Association between Lymphotoxin Alpha (-252G/A and -804C/A) Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-Analysis.

Kumar P, Misra S, Kumar A, Kishor Pandit A, Chakravarty K, Prasad K.

Acta Neurol Taiwan. 2016 Mar;25(1):10-7.


Role of Interleukin-10 (-1082A/G) gene polymorphism with the risk of ischemic stroke: a meta-analysis.

Kumar P, Yadav AK, Misra S, Kumar A, Chakravarty K, Prasad K.

Neurol Res. 2016 Sep;38(9):823-30. doi: 10.1080/01616412.2016.1202395.


BSR and BHPR guideline for the treatment of systemic sclerosis.

Denton CP, Hughes M, Gak N, Vila J, Buch MH, Chakravarty K, Fligelstone K, Gompels LL, Griffiths B, Herrick AL, Pang J, Parker L, Redmond A, van Laar J, Warburton L, Ong VH; BSR and BHPR Standards, Guidelines and Audit Working Group..

Rheumatology (Oxford). 2016 Oct;55(10):1906-10. doi: 10.1093/rheumatology/kew224. Review. No abstract available.


Association between Tumor Necrosis Factor-α (-238G/A and -308G/A) Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-Analysis.

Kumar P, Misra S, Kumar A, Pandit AK, Chakravarty K, Prasad K.

Pulse (Basel). 2016 Apr;3(3-4):217-28. doi: 10.1159/000443770. Review.


Association between Endothelial nitric oxide synthase G894T gene polymorphism and risk of ischemic stroke in North Indian population: a case-control study.

Kumar A, Misra S, Kumar P, Sagar R, Prasad K, Pandit AK, Chakravarty K, Kathuria P, Yadav AK.

Neurol Res. 2016 Jul;38(7):575-9. doi: 10.1080/01616412.2016.1181376.


Genetic association between inflammatory genes (IL-1α, CD14, LGALS2, PSMA6) and risk of ischemic stroke: A meta-analysis.

Misra S, Kumar P, Kumar A, Sagar R, Chakravarty K, Prasad K.

Meta Gene. 2016 Jan 19;8:21-9. doi: 10.1016/j.mgene.2016.01.003. Review.


Genetics of ischemic stroke: An Indian scenario.

Kumar A, Kumar P, Kathuria P, Misra S, Pandit AK, Chakravarty K, Prasad M.

Neurol India. 2016 Jan-Feb;64(1):29-37. doi: 10.4103/0028-3886.173645.


High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis.

Pandit AK, Kumar P, Kumar A, Chakravarty K, Misra S, Prasad K.

Acta Neurol Scand. 2016 Jul;134(1):22-8. doi: 10.1111/ane.12540. Review.


A two-phase model for drug release from microparticles with combined effects of solubilisation and recrystallisation.

Chakravarty K, Dalal DC.

Math Biosci. 2016 Feb;272:24-33. doi: 10.1016/j.mbs.2015.11.006.


Secondary vasculitis in autoimmune connective tissue diseases.

Chakravarty K, Ong VH, Denton CP.

Curr Opin Rheumatol. 2016 Jan;28(1):60-5. doi: 10.1097/BOR.0000000000000241. Review.


A case of multicentric carcinoid in a patient with psoriatic spondyloarthropathy.

George N, Depala A, Al Sweedan L, Chakravarty K.

Case Rep Rheumatol. 2015;2015:179696. doi: 10.1155/2015/179696.


Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.

Scott DL, Ibrahim F, Farewell V, O'Keeffe AG, Walker D, Kelly C, Birrell F, Chakravarty K, Maddison P, Heslin M, Patel A, Kingsley GH.

BMJ. 2015 Mar 13;350:h1046. doi: 10.1136/bmj.h1046.


Paget's disease: a clinical review.

Shah M, Shahid F, Chakravarty K.

Br J Hosp Med (Lond). 2015 Jan;76(1):25-30. doi: 10.12968/hmed.2015.76.1.25. Review.


Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids.

Ibrahim F, Choy E, Gordon P, Doré CJ, Hakim A, Kitas G, Isenberg D, Griffiths B, Lecky B, Chakravarty K, Winer J, Danko K, Cooper RG, White-Alao B, Scott DL.

Rheumatology (Oxford). 2015 Jun;54(6):1050-5. doi: 10.1093/rheumatology/keu442.


Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.

Hansi N, Thoua N, Carulli M, Chakravarty K, Lal S, Smyth A, Herrick A, Ogunbiyi O, Shaffer J, Mclaughlin J, Denton C, Ong V, Emmanuel AV, Murray CD.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-214-21. Review.


BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.

Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D, Luqmani R, Mills J, Mooney J, Venning M, Watts RA; BSR and BHPR Standards, Guidelines and Audit Working Group..

Rheumatology (Oxford). 2014 Dec;53(12):2306-9. doi: 10.1093/rheumatology/ket445. No abstract available.


Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice.

Yu XX, Watts LM, Manchem VP, Chakravarty K, Monia BP, McCaleb ML, Bhanot S.

PLoS One. 2013;8(7):e66923. doi: 10.1371/journal.pone.0066923.

Items per page

Supplemental Content

Loading ...
Support Center